Compounds > celecoxib

celecoxib and 4-nitroquinoline-1-oxide

celecoxib has been researched along with 4-nitroquinoline-1-oxide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farber, JL; Fong, LY; Jiang, Y; Zhang, L1
Byun, Y; Choi, Y; Kim, SY; Lee, C; Park, K; Yang, JH1
Abbasi, MM; Arbabi, F; Dustar, Y; Javadzadeh, Y; Khaki, AA; Roshangar, L; Sohrabi, M; Soleimani, J; Vatansever, S1
Das, SK; Dash, R; Fisher, PB; Maji, S; Panda, S; Pattanaik, L; Pellecchia, M; Quinn, BA; Samal, SK; Sarkar, D1

Other Studies

4 other study(ies) available for celecoxib and 4-nitroquinoline-1-oxide

ArticleYear
Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats.
    Journal of the National Cancer Institute, 2005, Jan-05, Volume: 97, Issue:1

    Topics: 4-Nitroquinoline-1-oxide; Animals; Apoptosis; Blotting, Western; Carcinogens; Carcinoma, Squamous Cell; Celecoxib; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diet; Disease Models, Animal; Esophageal Neoplasms; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Hyperplasia; Indomethacin; Isoenzymes; Male; Mutagens; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Tongue Neoplasms; Up-Regulation; Zinc

2005
Chemoprevention of 4-NQO-induced oral carcinogenesis by co-administration of all-trans retinoic acid loaded microspheres and celecoxib.
    Journal of controlled release : official journal of the Controlled Release Society, 2005, May-05, Volume: 104, Issue:1

    Topics: 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Celecoxib; Cyclooxygenase Inhibitors; Delayed-Action Preparations; Drug Therapy, Combination; Female; Liposomes; Male; Pyrazoles; Quinolones; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Sulfonamides; Tongue Neoplasms; Tretinoin

2005
The effect of dietary and topical celecoxib on 4-nitroquinoline-1-oxide-induced lingual epithelium alternations in rat.
    JPMA. The Journal of the Pakistan Medical Association, 2009, Volume: 59, Issue:11

    Topics: 4-Nitroquinoline-1-oxide; Administration, Topical; Analysis of Variance; Animals; Celecoxib; Cyclooxygenase Inhibitors; Diet; Disease Models, Animal; In Situ Nick-End Labeling; Male; Precancerous Conditions; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Tongue; Tongue Neoplasms

2009
Mcl-1 is an important therapeutic target for oral squamous cell carcinomas.
    Oncotarget, 2015, Jun-30, Volume: 6, Issue:18

    Topics: 4-Nitroquinoline-1-oxide; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy-Related Protein 5; Autophagy-Related Protein 7; bcl-X Protein; Beclin-1; Biphenyl Compounds; Carcinoma, Squamous Cell; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Female; Gossypol; Humans; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; Mitophagy; Mouth Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Nitrophenols; Piperazines; Proto-Oncogene Proteins; Quinolones; Random Allocation; RNA Interference; RNA, Small Interfering; Sulfonamides; Ubiquitin-Activating Enzymes; Xenograft Model Antitumor Assays

2015